Palvella Therapeutics PVLA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $206.39M+173% | $57.98M-30.6% | $63.57M+228% | $70.43M+257% | $75.63M+296% | ||
| $263.23M+231% | $58.99M-33.1% | $66.94M— | $73.75M— | $79.44M— | ||
| $55.46M— | $0— | —— | —— | —— | ||
| $263.76M+232% | $59.56M-32.5% | $66.94M+226% | $73.75M+194% | $79.44M+169% | ||
| $5.44M+22.6% | $4.6M+0.2% | $3.48M+335% | $4.56M+370% | $4.44M+193% | ||
| $9.12M+1.5% | $11.34M-5.8% | $10.31M+142% | $9.62M+51.5% | $8.98M+19.2% | ||
| $31.45M+31.8% | $31.58M+23.2% | $28.26M— | $25.97M— | $23.86M— | ||
| $14K+27.3% | $12K+9.1% | $11K+1,000% | $11K+1,000% | $11K+1,000% | ||
| -$151.22M-48.4% | -$135.45M-44.5% | -$122.74M+62.4% | -$111.39M+65.6% | -$101.92M+68.1% | ||
| $232.31M+318% | $27.98M-55.3% | $38.68M+144% | $47.78M+159% | $55.58M+172% | ||
| $263.76M+232% | $59.56M-32.5% | $66.94M+226% | $73.75M+194% | $79.44M+169% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Palvella Therapeutics's total assets?
- Palvella Therapeutics (PVLA) holds $263.8M in total assets, up 232.0% year over year.
- How much debt does Palvella Therapeutics have?
- Palvella Therapeutics carries $584.0K in total debt against $232.3M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Palvella Therapeutics have?
- Palvella Therapeutics holds $206.4M in cash and equivalents.
- Can Palvella Therapeutics cover its short-term obligations?
- Its current ratio is 28.88 — current assets exceed current liabilities.
- Where does Palvella Therapeutics's balance sheet data come from?
- Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
